MVA85A-IMX313

· University of Oxford

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MVA85A-IMX313, covering 2014-12-16 to 2014-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults [Phase 1]

See pricing